A popular weight-loss drug may be changing how doctors treat obesity—but scientists are just starting to uncover exactly how ...

Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...

New research compared the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. Here's what the study ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...

Doctors are continuing to issue warnings regarding the illicit use of Ozempic, Wegovy and Mounjaro as weight loss injections, ...

A global review reveals over 100 new dementia drugs which could halt or even reverse the disease are going through clinical ...

Ozempic teeth is the latest concern associated with the ‘miracle’ weight loss drug Ozempic Read to know more about this side ...

Regeneron Pharmaceuticals (NasdaqGS:REGN) recently announced a strategic in-licensing agreement with Hansoh Pharmaceuticals, acquiring rights for a dual GLP-1/GIP receptor agonist, HS-20094.

Dementia experts have said that "hope is on the horizon" after a new review shows a rise in the number of potential drugs ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...